Waters launches charge detection MS technology to accelerate next-gen biotherapeutics
New Xevo™ CDMS system will have a significant impact on scientists’ ability to analyze and categorize large molecules central to next-generation therapeutics
New Xevo™ CDMS system will have a significant impact on scientists’ ability to analyze and categorize large molecules central to next-generation therapeutics
In this guest editorial, Eric Morreale, PhD explores global reflex testing trends, strategies, and evolving policies
Dr. Werner Lanthaler will strengthen FairJourney Biologics’ global position as a highly efficient partner for antibody discovery and development
Optimized, automated protocols on SPT Labtech’s firefly®+ using Agilent’s SureSelect Max DNA Library Prep Kit supports high-throughput sequencing in clinical research, oncology, and precision medicine
Partnership to enable automated workflows for 10x Genomics’ Chromium Single Cell Platform on SPT Labtech’s firefly liquid handling platform
Reimagining clinical microbiology with key technologies and long-acting therapies
New Panther Fusion Gastrointestinal Bacterial and Expanded Bacterial Assays deliver tailored, actionable diagnostic results to support fast and informed patient care
The knowledge could reduce the risk of severe bowel complications from radiotherapy, heralding a more personalized approach to prostate cancer treatment
Chromeleon™ 7.4 unifies chromatography and MS data in one streamlined, scalable platform – enabling remote access, centralized storage, full traceability, and automated compliance features for labs in biopharma, food safety, and environmental testing
SVP Karan Arora shares how advanced assays, AI, and pharma partnerships are shaping the future of targeted oncology care
Championing biomedical science, combating antimicrobial resistance, and inspiring future generations in Africa
Development agreement applies Optimer binders to cancer imaging and therapeutics
Joint consensus recommendation includes organizational representation from AMP, ASCO and CAP
This tool will be launched as part of Roche’s new chronic kidney disease algorithm panel to support care across the stages of the disease which affects 700 million people globally